Discussion/Follow-up Care For patients with COVID-19 and STEMI, percutaneous coronary intervention remains the treatment of choice. For patients with COVID-19 and NSTEMI, conservative therapy is ...

PARIS, France—Among patients with acute MI and occlusive disease on invasive angiography, those presenting without ST-segment elevation on the initial ECG fare worse than those with STEMI, researchers ...

The benefit of fractional flow reserve (FFR)–guided complete revascularization in patients with ST-segment elevation myocardial infarction (STEMI) and multivessel coronary artery disease remains ...

Patients were eligible if they had ST elevation myocardial infarction (STEMI) or large non-ST elevation myocardial infarction (NSTEMI). Study subjects were randomized within 72 hours of PCI to either ...

Over the period July 1999 to June 2002, 20,881 patients were admitted to the hospital with ACSs, of whom 1,763 (8.4%) presented with atypical symptoms. The dominant presenting symptoms in these ...

The benefit of beta-blockers after myocardial infarction in patients with a preserved left ventricular ejection fraction (LVEF) is unclear. We conducted a meta-analysis at the individual-patient level ...

New European Society of Cardiology (ESC) guidelines on the management of acute coronary syndromes (ACS) have for the first time combined ST-elevation MI (STEMI), non-ST-elevation MI (NSTEMI), and ...

Test your knowledge of Coronary Artery Disease - Unstable Angina/Non-STEMI with this ready-made quiz. Which of the following approaches to medical therapy is appropriate during unstable angina or ...